Back to results
US 2015/0174061 A1Published application
Intranasal naloxone compositions and methods of making and using same
AssigneeAntiOp, Inc.
InventorsJoseph Wyse, Michael Paul DeHart
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.
Claims21
A composition comprising
- a. from about 5 mg/mL to about 50 mg/mL of an opioid antagonist;
- b. from about 5 mM to about 50 mM citric acid;
- c. from about 2 to about 20 mM disodium ethylene diamine tetraacetic acid (EDTA);
- d. from about 0.1 to about 2 weight % benzyl alcohol;
- and
- e. a carrier.
3 more elements
21-26. (canceled)
Dependencies are inferred from the claim text.